168 related articles for article (PubMed ID: 16981420)
21. [Cholestatic liver diseases: diagnosis and therapy of primary sclerosing cholangitis].
Opitz OG; Thimme R; Kreisel W
Dtsch Med Wochenschr; 2002 Sep; 127(36):1827-30. PubMed ID: 12215927
[No Abstract] [Full Text] [Related]
22. [Autoimmune cholestasis syndrome. Ursodeoxycholic acid is the drug standard].
Stiefelhagen P
MMW Fortschr Med; 2007 May; 149(21):49. PubMed ID: 17668736
[No Abstract] [Full Text] [Related]
23. Management of autoimmune and cholestatic liver disorders.
Krok KL; Munoz SJ
Clin Liver Dis; 2009 May; 13(2):295-316. PubMed ID: 19442920
[TBL] [Abstract][Full Text] [Related]
24. [Use of ursodeoxycholic acid combined with silymarin in the treatment of chronic ethyl-toxic hepatopathy].
Bettini R; Gorini M
Clin Ter; 2002; 153(5):305-7. PubMed ID: 12510413
[TBL] [Abstract][Full Text] [Related]
25. A child with Kabuki syndrome and primary sclerosing cholangitis successfully treated with ursodiol and cholestryamine.
Suskind DL; Finn L; Wahbeh G; Christie D; Horslen S
J Pediatr Gastroenterol Nutr; 2006 Oct; 43(4):542-4. PubMed ID: 17033534
[No Abstract] [Full Text] [Related]
26. Gene expression profiling of early primary biliary cirrhosis: possible insights into the mechanism of action of ursodeoxycholic acid.
Chen L; Borozan I; Milkiewicz P; Sun J; Meng X; Coltescu C; Edwards AM; Ostrowski MA; Guindi M; Heathcote EJ; McGilvray ID
Liver Int; 2008 Aug; 28(7):997-1010. PubMed ID: 18422935
[TBL] [Abstract][Full Text] [Related]
27. Autoimmune diseases of the liver and biliary tract and overlap syndromes in childhood.
Maggiore G; Riva S; Sciveres M
Minerva Gastroenterol Dietol; 2009 Mar; 55(1):53-70. PubMed ID: 19212308
[TBL] [Abstract][Full Text] [Related]
28. Treatment of primary biliary cirrhosis: therapy with choleretic and immunosuppressive agents.
Silveira MG; Lindor KD
Clin Liver Dis; 2008 May; 12(2):425-43; x-xi. PubMed ID: 18456189
[TBL] [Abstract][Full Text] [Related]
29. The benign course of liver disease in adults with cystic fibrosis and the effect of ursodeoxycholic acid.
Desmond CP; Wilson J; Bailey M; Clark D; Roberts SK
Liver Int; 2007 Dec; 27(10):1402-8. PubMed ID: 18036103
[TBL] [Abstract][Full Text] [Related]
30. The importance of serum bile acid level analysis and treatment with ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a case series from central Europe.
Ambros-Rudolph CM; Glatz M; Trauner M; Kerl H; Müllegger RR
Arch Dermatol; 2007 Jun; 143(6):757-62. PubMed ID: 17576942
[TBL] [Abstract][Full Text] [Related]
31. [Intrahepatic cholestasis of pregnancy treated with ursodeoxycholic acid. Results from a two-year survey at Rigshospitalet, Skejby Hospital and Odense University Hospital].
Jochumsen KM; Svane D; Bødker B; Skajaa K; Westergaard JG
Ugeskr Laeger; 2003 Sep; 165(40):3825-8. PubMed ID: 14560505
[No Abstract] [Full Text] [Related]
32. Pregnancy in women with ursodeoxycholic acid-treated primary biliary cirrhosis.
Poupon R; Chrétien Y; Chazouillères O; Poupon RE
J Hepatol; 2005 Mar; 42(3):418-9. PubMed ID: 15710226
[No Abstract] [Full Text] [Related]
33. Hepatic graft-versus-host disease resembling acute hepatitis: additional treatment with ursodeoxycholic acid.
Chiba T; Yokosuka O; Kanda T; Fukai K; Imazeki F; Saisho H; Nishimura M; Saito Y
Liver; 2002 Dec; 22(6):514-7. PubMed ID: 12445178
[TBL] [Abstract][Full Text] [Related]
34. Management of autoimmune liver disease.
Maggs J; Cullen S
Minerva Gastroenterol Dietol; 2009 Jun; 55(2):173-206. PubMed ID: 19305377
[TBL] [Abstract][Full Text] [Related]
35. [A 67 year-old man consults for icterus].
Couchard AC; Panis Y
J Chir (Paris); 2002 Jun; 139(3):166-70. PubMed ID: 12391669
[No Abstract] [Full Text] [Related]
36. Autoimmune hepatitis overlap syndromes: an evaluation of treatment response, long-term outcome and survival.
Al-Chalabi T; Portmann BC; Bernal W; McFarlane IG; Heneghan MA
Aliment Pharmacol Ther; 2008 Jul; 28(2):209-20. PubMed ID: 18433467
[TBL] [Abstract][Full Text] [Related]
37. Ursodeoxycholic acid in the treatment of AIDS-associated cholangiopathy.
Castiella A; Iribarren JA; López P; Arrizabalaga J; Rodríguez F; von Wichmann MA; Arenas JI
Am J Med; 1997 Aug; 103(2):170-1. PubMed ID: 9274905
[No Abstract] [Full Text] [Related]
38. Portal hypertension and primary biliary cirrhosis: effect of long-term ursodeoxycholic acid treatment.
Huet PM; Vincent C; Deslaurier J; Coté J; Matsutami S; Boileau R; Huet-van Kerckvoorde J
Gastroenterology; 2008 Nov; 135(5):1552-60. PubMed ID: 18722374
[TBL] [Abstract][Full Text] [Related]
39. Pathogenesis and medical therapy of primary sclerosing cholangitis.
van Milligen de Wit AW
Eur J Gastroenterol Hepatol; 1999 Aug; 11(8):940. PubMed ID: 10514135
[No Abstract] [Full Text] [Related]
40. Effect of ursodeoxycholic acid on granulomatous liver disease due to sarcoidosis.
Alenezi B; Lamoureux E; Alpert L; Szilagyi A
Dig Dis Sci; 2005 Jan; 50(1):196-200. PubMed ID: 15712660
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]